Adjuvant chemotherapy for oesophagogastric cancer with epirubicin, cisplatin and infusional 5-fluorouracil (ECF): a Royal Marsden pilot study.

Previous trials of adjuvant chemotherapy for oesophagogastric cancer have shown only modest or no improvement in survival. However, the regimens used in these studies produce low response rates in patients with advanced disease. ECF is a new regimen which results in higher response rates and may the...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Bamias, A., Cunningham, D., Nicolson, V., Norman, A., Hill, M., Nicolson, M., O'Brien, M., Webb, A., Hill, A.
Formato: Artigo
Lenguaje:Inglês
Publicado: Nature Publishing Group 1995
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2033623/
https://ncbi.nlm.nih.gov/pubmed/7880742
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares